Published in Toxicol Appl Pharmacol on September 01, 1977
Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ Health Perspect (2005) 1.54
Discriminating different classes of toxicants by transcript profiling. Environ Health Perspect (2004) 1.16
Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations. Biochem J (1978) 0.90
Sequential biochemical and histological changes in rats treated with aflatoxin B1. Br J Cancer (1980) 0.77
Tremorgenic toxin from Penicillium cyclopium grown on food materials. Nature (1968) 1.90
Paneth cell-like metaplasia of the prostate gland. Arch Pathol Lab Med (1992) 1.51
Aflatoxin and Reye's syndrome: a case control study. Pediatrics (1980) 1.50
Bioproduction and purification of rubratoxin B. Appl Microbiol (1968) 1.28
Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev (1990) 1.26
Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J Pharmacol Exp Ther (2000) 1.23
Investigation of reported aflatoxin production by fungi outside the Aspergillus flavus group. Appl Microbiol (1968) 1.22
Teratogenic effects of ochratoxin A in mice. Teratology (1974) 1.18
Tremorgenic toxins produced by soil fungi. Appl Environ Microbiol (1979) 1.17
Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs. Drug Metab Dispos (1983) 1.17
Prenatal effects of Ochratoxin A in hamsters. Teratology (1976) 1.06
A review of the role of tissue repair as an adaptive strategy: why low doses are often non-toxic and why high doses can be fatal. Food Chem Toxicol (1996) 1.05
Aflatoxicosis in swine. J Am Vet Med Assoc (1978) 1.03
Role of hepatocellular regeneration in CCl4 autoprotection. Toxicol Pathol (1991) 1.02
Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab Dispos (2001) 1.01
Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes. Crit Rev Toxicol (2007) 1.00
Production and biological activity of secalonic Acid d. Appl Environ Microbiol (1980) 0.97
Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone. Arch Toxicol (1996) 0.95
Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology (1995) 0.95
PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirex. Toxicol Appl Pharmacol (1991) 0.94
Acute toxicity of penitrem A in dogs. Toxicol Appl Pharmacol (1976) 0.94
Potentiation of CCl4 hepatotoxicity and lethality by chlordecone in female rats. Toxicology (1983) 0.94
Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae. Mutat Res (1978) 0.94
High-performance liquid chromatographic analysis of the mycotoxin secalonic acid D and its application to biological fluids. J Chromatogr (1981) 0.93
Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ Health Perspect (1995) 0.92
G2 subpopulation in rat liver induced into mitosis by low-level exposure to carbon tetrachloride: an adaptive response. Toxicol Appl Pharmacol (1993) 0.92
Toxicity of Secalonic acid D. J Toxicol Environ Health (1979) 0.92
Mycotoxins: a review of biological effects and their role in human diseases. Clin Toxicol (1980) 0.91
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer (1996) 0.91
Hepatic cell division and tissue repair: a key to survival after liver injury. Mol Med Today (1996) 0.90
The failure of trichothecene mycotoxins and whole cultures of Fusarium tricinctum to cause experimental haemorrhagic syndromes in calves and pigs. Vet Rec (1979) 0.89
Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study. Exp Mol Pathol (1983) 0.89
Mutagenicity of secalonic acid D in mice. J Environ Pathol Toxicol (1980) 0.89
The genotoxic potential of nicotine and its major metabolites. Mutat Res (1995) 0.89
Teratogenicity of secalonic acid D in mice. J Toxicol Environ Health (1981) 0.88
Potentiation of the hepatotoxicity of carbon tetrachloride following preexposure to chlordecone (kepone) in the male rat. Toxicol Appl Pharmacol (1979) 0.87
Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol Appl Pharmacol (2000) 0.87
Primary epithelioid angiosarcoma of the adrenal gland. Ann Diagn Pathol (2001) 0.87
Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a morphometric and biochemical study. Exp Mol Pathol (1983) 0.87
Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats. Toxicology (1982) 0.87
Mycotoxin from Penicillium puberulum. J Bacteriol (1967) 0.86
Protection of hepatotoxic and lethal effects of CCl4 by partial hepatectomy. Toxicol Pathol (1989) 0.86
Potentiation of halomethane hepatotoxicity: chlordecone and carbon tetrachloride. Fundam Appl Toxicol (1984) 0.86
Effects of rubratoxin B on prenatal development in mice. Bull Environ Contam Toxicol (1973) 0.86
Aflatoxin B1 and Reye's syndrome. Lancet (1978) 0.86
HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med (1994) 0.86
Tissue injury and repair as parallel and opposing responses to CCl4 hepatotoxicity: a novel dose-response. Toxicology (1997) 0.86
Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther (1988) 0.86
Effect of aflatoxin B and rubratoxin B on bacteriophage and rabbit cornea cells. Bull Environ Contam Toxicol (1976) 0.86
Potentiation of CCl4 lethality by chlordecone. Toxicol Lett (1982) 0.85
Colchicine antimitosis abolishes CCl4 autoprotection. Toxicol Pathol (1991) 0.85
Immunohistochemical analysis of prostate specific antigen in breast cancer. Breast Cancer Res Treat (2001) 0.85
Teratogenic and dominant lethal studies of patulin in mice. Toxicology (1978) 0.84
Temporal changes in tissue repair permit survival of diet-restricted rats from an acute lethal dose of thioacetamide. Toxicol Sci (1998) 0.84
Effects of rubratoxin B on the kinetics of cationic and substrate activation of (Na+-K+)-ATPase and p-nitrophenyl phosphatase. J Biol Chem (1978) 0.83
Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia-reperfusion injury of rat liver. Hepatology (1997) 0.83
High-performance liquid chromatographic analysis of the mycotoxin citrinin and its application to biological fluids. J Chromatogr (1980) 0.83
Suppression of cellular immune responses in BALB/c mice following oral exposure to permethrin. Bull Environ Contam Toxicol (1995) 0.83
Nutritional impact on the final outcome of liver injury inflicted by model hepatotoxicants: effect of glucose loading. FASEB J (1995) 0.83
Nutritional modulation of the final outcome of hepatotoxic injury by energy substrates: an hypothesis for the mechanism. Med Hypotheses (1996) 0.82
Effect of prenatal administration of T-2 toxin to mice. Res Commun Chem Pathol Pharmacol (1975) 0.82
Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis. Biochim Biophys Acta (1989) 0.82
Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats. Fundam Appl Toxicol (1996) 0.82
Effects of prenatal administration of citrinin and viriditoxin to mice. Food Cosmet Toxicol (1976) 0.82
Excessive hepatic accumulation of intracellular Ca2+ in chlordecone potentiated CCl4 toxicity. Toxicology (1984) 0.82
Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol (1993) 0.81
Hepatic microsomal metabolism of CCL4 after pretreatment with chlordecone, mirex, or phenobarbital in male rats. Drug Metab Dispos (1983) 0.81
Aflatoxin B1; its role in the etiology of Reye's syndrome. Pediatrics (1979) 0.81
Analysis of aflatoxin B1 in human tissues with high-pressure liquid chromatography. Toxicol Appl Pharmacol (1981) 0.81
Role of hepatocellular regeneration in chlordecone potentiated hepatotoxicity of carbon tetrachloride. Arch Toxicol (1989) 0.81
Efficient tissue repair underlies the resiliency of postnatally developing rats to chlordecone + CCl4 hepatotoxicity. Toxicology (1996) 0.81
Protection from CCl4 toxicity by prestimulation of hepatocellular regeneration in partially hepatectomized gerbils. Biochem Pharmacol (1991) 0.80
Nitrofen: a review and perspective. Toxicology (1983) 0.80
Diet restriction enhances compensatory liver tissue repair and survival following administration of lethal dose of thioacetamide. Toxicol Appl Pharmacol (1998) 0.80
The absence of genotoxicity of sucralose. Food Chem Toxicol (2010) 0.80
Metabolism and effects of hexachlorobenzene on hepatic microsomal enzymes in the rat. J Agric Food Chem (1975) 0.80
Resiliency to amplification of carbon tetrachloride hepatotoxicity by chlordecone during postnatal development in rats. Pediatr Res (1993) 0.80
Protection from chlordecone (Kepone)-potentiated CCl4 hepatotoxicity in rats by fructose 1,6-diphosphate. Int J Biochem (1989) 0.80
Protection of chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality by partial hepatectomy. Arch Toxicol (1988) 0.80
Ninety-day inhalation study in rats, using aged and diluted sidestream smoke from a reference cigarette: DNA adducts and alveolar macrophage cytogenetics. Fundam Appl Toxicol (1993) 0.80
Effect of amiodarone on Na+-, K+-ATPase and Mg2+-ATPase activities in rat brain synaptosomes. Cell Biochem Funct (1986) 0.80
Aflatoxin B1 in the serum of a patient with primary hepatic carcinoma. Environ Res (1980) 0.80
Effect of the mycotoxin, penicillic acid, on Tetrahymena pyriformis. Toxicon (1977) 0.80
Renal cell carcinoma with intravascular lymphomatosis: a case report of unusual collision tumors with review of the literature. Arch Pathol Lab Med (2001) 0.80
Pivotal role of hepatocellular regeneration in the ultimate hepatotoxicity of CCl4 in chlordecone-, mirex-, or phenobarbital-pretreated rats. Toxicol Pathol (1992) 0.79
Disposition of [14C]secalonic acid D in male mice. Toxicol Appl Pharmacol (1981) 0.79
Toxicant-inflicted injury and stimulated tissue repair are opposing toxicodynamic forces in predictive toxicology. Regul Toxicol Pharmacol (1999) 0.79
Effect of colchicine on hepatobiliary function in CCl4 treated rats. Biochem Pharmacol (1991) 0.79
Effects of citrinin on renal function and structure. Toxicology (1980) 0.79
Hepatotoxicity and lethality of halomethanes in Mongolian gerbils pretreated with chlordecone, phenobarbital or mirex. Arch Toxicol (1991) 0.79
Ongoing hepatocellular regeneration and resiliency toward galactosamine hepatotoxicity. Arch Toxicol (1992) 0.79
Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality. Toxicol Appl Pharmacol (2001) 0.79
Survey of the sensitivity of microorganisms to rubratoxin B. Appl Microbiol (1970) 0.79
Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity. Environ Health Perspect (1996) 0.79
Evaluation of renal function in saccharin treated rats. Toxicology (1981) 0.79
In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats. J Biochem Toxicol (1990) 0.79
Hepatic failure leads to lethality of chlordecone-amplified hepatotoxicity of carbon tetrachloride. Fundam Appl Toxicol (1993) 0.79